Dados B3 › CSED3 × RADL3
CSED3 × RADL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CSED3 | RADL3 | year |
|---|---|---|---|
| ROE | 19.4% | 18.9% | 2025 |
| ROIC | 29.9%! | 24.8% | 2025 |
| ROA | 6.4% | 5.5% | 2025 |
| Gross margin | 50.9% | 29.3% | 2025 |
| EBIT margin | 21.6% | 6.2% | 2025 |
| Net margin | 10.5% | 2.9% | 2025 |
| Net debt/EBITDA | 0.63x | 0.69x | 2025 |
| Current ratio | 1.53x | 1.46x | 2025 |
| Revenue growth (1y) | 10.4% | 13.8% | 2025 |
| Revenue growth (5y CAGR) | 9.5% | 17.1% | 2025 |
| Piotroski F-Score | 8/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CSED3 | RADL3 | year |
|---|---|---|---|
| P/E | 7.54x | 32.24x | 2025 |
| P/B | 1.41x | 5.71x | 2025 |
| EV/EBITDA | 3.18x | 9.37x | 2025 |
| FCF yield | 32.7% | 2.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:45 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:45 UTC. If this does not match /saude, you are reading a cached copy.